Literature DB >> 9890204

National survey of the use of endomyocardial biopsy in Japan.

S Hiramitsu1, M Hiroe, A Uemura, K Kimura, H Hishida, S Morimoto.   

Abstract

A national survey of endomyocardial biopsy procedures was conducted in Japan. Questionnaires were mailed to 852 institutions and statistical analysis of the 213 completed questionnaires (25.0% of the total) was performed. Cardiac biopsies were being performed at 134 of these institutions (62.9%), representing a 5.5-fold increase over 1980. A total of 19,964 cardiac biopsies have been performed in Japan. Specimens were obtained from the right ventricle at 113 institutions, and from the left ventricle at 76 centers. The Konno-Sakakibara bioptome was used at 32 institutions, whereas the long sheath method was used at 98 institutions. Sixty of the institutions (44.8%) had encountered ventricular wall perforation. The perforation rate of the two ventricles combined was 0.7% (147 of 19,964 cases), with a mortality rate of 0.05% (10 of 19,964 cases). Endomyocardial biopsy has become widespread in Japan, and its safety was ascertained by this national survey.

Mesh:

Year:  1998        PMID: 9890204     DOI: 10.1253/jcj.62.909

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  3 in total

Review 1.  Current status of endomyocardial biopsy.

Authors:  Aaron M From; Joseph J Maleszewski; Charanjit S Rihal
Journal:  Mayo Clin Proc       Date:  2011-11       Impact factor: 7.616

2.  Endomyocardial biopsy via the femoral access - still safe and valuable diagnostic tool.

Authors:  Sylwia Sławek; Aleksander Araszkiewicz; Agnieszka Gaczkowska; Justyna Koszarska; Damian Celiński; Marek Grygier; Maciej Lesiak; Stefan Grajek
Journal:  BMC Cardiovasc Disord       Date:  2016-11-15       Impact factor: 2.298

Review 3.  How to Identify Transthyretin Cardiac Amyloidosis at an Early Stage.

Authors:  Yasuhiro Izumiya; Hiroya Hayashi; Hirotoshi Ishikawa; Atsushi Shibata; Minoru Yoshiyama
Journal:  Intern Med       Date:  2020-07-21       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.